BalmerN.V. & LeistM. (2014). Epigenetics and transcriptomics to detect adverse drug effects in model systems of human development. Basic & Clinical Pharmacology & Toxicology115, 59–68.
2.
BalmerN.V., KlimaS., RempelE., IvanovaV.N., KoldeR., WengM.K., MeganathanK., HenryM., SachinidisA., BertholdM.R., HengstlerJ.G., RahnenführerJ., WaldmannT. & LeistM. (2014). From transient transcriptome responses to disturbed neurodevelopment: Role of histone acetylation and methylation as epigenetic switch between reversible and irreversible drug effects. Archives of Toxicology88, 1451–1468.
3.
GrabingerT., LuksL., KostadinovaF., ZimberlinC., MedemaJ.P., LeistM. & BrunnerT. (2014). Ex vivo culture of intestinal crypt organoids as a model system for assessing cell death induction in intestinal epithelial cells and enteropathy. Cell Death & Disease5, e1228.
4.
SmirnovaL., BlockK., SittkaA., OelgeschlägerM., SeilerA.E.M. & LuchA. (2014). MicroRNA profiling as tool for in vitro developmental neurotoxicity testing: The case of sodium valproate. PLoS One9, e98892.
5.
ZimmerB., PalloccaG., DreserN., FoersterS., WaldmannT., WesterhoutJ., JulienS., KrauseK.H., van ThrielC., HengstlerJ.G., SachinidisA., BosgraS. & LeistM. (2014). Profiling of drugs and environmental chemicals for functional impairment of neural crest migration in a novel stem cell-based test battery. Archives of Toxicology88, 1109–1126.
